Elon Musk claims the first human patient received a Neuralink implant

Elon Musk claims the first human patient received a Neuralink implant

Bloomberg reports that thousands of people have expressed interest in participating in FDA trials for Neuralink.
NurFoto

  • Elon Musk claimed that Neuralink’s first human patient received a brain implant at X.
  • The neurotechnology company received FDA approval to begin human trials last year.
  • Musk said the patient was “recovering well” and that preliminary results “revealed promising neuronal spikes.”

In a post on Monday, Elon Musk claimed that a Neuralink brain implant had been placed in the brain of a human patient for the first time.

“The first person received an implant from @Neuralink yesterday and is doing well,” Musk said he wrote. “Preliminary results show promising neural spike detection.”

The first product is called Telepathy, Musk said in his follow-up postadding that the device “allows you to control your phone or computer and through them almost any device with just a thought. Early users will lose their membership.”

“Imagine if Stephen Hawking could communicate faster than a fast typist or an auctioneer,” he said. “That’s the point.”

Musk previously said the Neuralink device would act as a “fitbit in your skull” to record and stimulate brain activity, and claimed the implant would eventually “solve” conditions including. autism and schizophrenia.

Business Insider’s Hilary Brueck reported in 2091 that neuroscientists believe Neuralink cannot “solve” mental health conditions or change the developmental architecture of the brain when it is affected by diseases such as Alzheimer’s. However, the technology could be effective in stimulating the electrodes, thereby helping paralyzed patients gain better mobility or blind patients regain vision.

Neuralink representatives did not immediately respond to Business Insider’s request for comment.

Years are made

Billionaire Tesla and SpaceX CEO promises that Neuralink will soon start human trials from 2019.

The FDA initially denied Neuralink’s request for approval to test it in humans last March, citing concerns that the brain chips could overheat or move in the brain. Reuters informed. Approval was finally given in May 2023.

The approval prompted thousands of potential patients to volunteer to have part of their skull removed and implanted.

When the company started hiring for him first human trials In September, Neuralink a blog post he looked for patients with spinal cord injuries, paralysis in all four limbs, or a diagnosis of amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease.

While Neuralink says it hopes to help people with neurological disorders with its implanted devices, the company also aims to develop an implant that would allow people to send messages or play games using only their thoughts.

Musk, who claims he plans to implant one of the chips in his own brain sometime in 2022, said that through Neuralink, he aims to create an interface that is powerful enough to allow people to process information faster, speed up cognition and “get information.” a kind of symbiosis with artificial intelligenceā€.

But some experts are skeptical. In 2019, Business Insider’s Brueck spoke with Columbia University neuroscientist Randy Bruno, who said he wasn’t sure Neuralink could ever facilitate such super-advanced thinking power because of the brain’s fundamental function.

“Neurons work at a certain speed,” said Bruno, a researcher who implanted probes into mouse brains. “I think it will ultimately be limiting.”

Others raised concerns about the ethics of the technology and its development, and Musk’s promises about what Neuralink could do.

“Certainly, we have to hope that the intervention ultimately works as advertised with few potential adverse side effects,” Jason T. Eberl, professor and director of the Albert Gnaeghi Center for Health Ethics at Saint Louis University, told Healthline in 2022. “But any for-profit medical device company is also interested in building a consumer base, so they sometimes make big claims.”

Have you filled out an application for Neuralink’s human trials or have a tip? Please contact [email protected] from non-work email.

Leave a Comment

Your email address will not be published. Required fields are marked *